These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10996354)

  • 1. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels.
    Brites FD; Bonavita CD; De Geitere C; Cloës M; Delfly B; Yael MJ; Fruchart J; Wikinski RW; Castro GR
    Atherosclerosis; 2000 Sep; 152(1):181-92. PubMed ID: 10996354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cholesterol efflux promotion in well-trained soccer players.
    Brites F; Verona J; De Geitere C; Fruchart JC; Castro G; Wikinski R
    Metabolism; 2004 Oct; 53(10):1262-7. PubMed ID: 15375780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase.
    Tato F; Vega GL; Grundy SM
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):56-63. PubMed ID: 9012638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.
    de la Llera Moya M; Atger V; Paul JL; Fournier N; Moatti N; Giral P; Friday KE; Rothblat G
    Arterioscler Thromb; 1994 Jul; 14(7):1056-65. PubMed ID: 8018660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
    Atger V; de la Llera Moya M; Bamberger M; Francone O; Cosgrove P; Tall A; Walsh A; Moatti N; Rothblat G
    J Clin Invest; 1995 Dec; 96(6):2613-22. PubMed ID: 8675626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid transfer proteins, hypertriglyceridemia, and reduced high-density lipoprotein cholesterol.
    Sparks D; Frohlich JJ; Pritchard PH
    Am Heart J; 1991 Aug; 122(2):601-7. PubMed ID: 1858655
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.
    Hayek T; Azrolan N; Verdery RB; Walsh A; Chajek-Shaul T; Agellon LB; Tall AR; Breslow JL
    J Clin Invest; 1993 Sep; 92(3):1143-52. PubMed ID: 8376576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?
    Quintão EC
    Atherosclerosis; 1995 Jul; 116(1):1-14. PubMed ID: 7488324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
    Iglesias A; Contreras JA; Martínez-Pardo M; Entrala A; Herrera E; Lasunción MA
    Clin Chim Acta; 1993 Nov; 221(1-2):73-89. PubMed ID: 8149644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages.
    Harada LM; Carvalho MD; Passarelli M; Quintão EC
    Atherosclerosis; 1998 Jul; 139(1):65-75. PubMed ID: 9699893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
    Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
    Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alcohol on the major steps of reverse cholesterol transport.
    Serdyuk AP; Metelskaya VA; Ozerova IN; Kovaltchouk NV; Olferiev AM; Bubnova MG; Perova NV; Jauhiainen M; Lasselin C; Castro G
    Biochemistry (Mosc); 2000 Nov; 65(11):1310-5. PubMed ID: 11112849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
    de Vries R; Groen AK; Perton FG; Dallinga-Thie GM; van Wijland MJ; Dikkeschei LD; Wolffenbuttel BH; van Tol A; Dullaart RP
    Atherosclerosis; 2008 Feb; 196(2):733-41. PubMed ID: 17275009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure.
    Martinelli AEM; Maranhão RC; Carvalho PO; Freitas FR; Silva BMO; Curiati MNC; Kalil Filho R; Pereira-Barretto AC
    Lipids Health Dis; 2018 Oct; 17(1):242. PubMed ID: 30342531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.
    Adlouni A; El Messal M; Saïle R; Parra H; Fruchart J; Ghalim N
    Atherosclerosis; 2000 Oct; 152(2):433-40. PubMed ID: 10998472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
    Greaves KA; Going SB; Fernandez ML; Milliken LA; Lohman TG; Bassford T; McNamara DJ
    Metabolism; 2003 Mar; 52(3):282-9. PubMed ID: 12647264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.